Streetbeat News

Products Services

BTCUSD

Robert F. Kennedy Jr. questions Donald Trump's pro-cryptocurrency stance as both vie for crypto-holder support in the 2024 presidential race. Kennedy expressed skepticism at the Bitcoin 2024 conference, while Trump is set to speak on Saturday. Kennedy pledged to make Bitcoin tax-free and build a reserve if elected.

Portfolio Pulse from Navdeep Yadav

July 27, 2024 | 6:36 am

GOOG

GOOGL

Deepwater Asset Management's Gene Munster and Doug Clinton have downplayed concerns that OpenAI's SearchGPT could significantly threaten Alphabet Inc.'s Google Search. Despite a minor dip in Google's stock following the announcement of SearchGPT, the analysts believe that the new AI-powered search engine does not pose a substantial threat to Google's dominance.

Portfolio Pulse from Ananya Gairola

July 27, 2024 | 4:00 am

ARKB

Cryptocurrency markets are trading higher as the Bitcoin Conference awaits Donald Trump’s keynote speech. Bitcoin, Ethereum, Dogecoin, and other cryptocurrencies have seen significant gains. Notable statistics include an increase in large transactions and daily active addresses. The Michigan state pension fund disclosed holdings in the ARK 21Shares Bitcoin ETF. Other developments include Franklin Templeton's partnership with SBI Holdings to launch a digital asset management company in Japan and concerns raised by Senator Warren over foreign-owned crypto mining operations in the US.

Portfolio Pulse from Khyathi Dalal

July 26, 2024 | 8:29 pm

PBI

Logistics startup Stord has acquired a portion of Pitney Bowes' e-commerce business. This move is expected to enhance Stord's logistics capabilities and market reach.

Portfolio Pulse from Benzinga Newsdesk

July 26, 2024 | 8:24 pm

CGTX

Cognition Therapeutics shares are trading higher following the announcement of an upcoming investor presentation to discuss results from its phase 2 SHINE study of CT1812 on July 29, 2024.

Portfolio Pulse from Benzinga Newsdesk

July 26, 2024 | 8:21 pm

CGTX

Cognition Therapeutics, Inc. (NASDAQ:CGTX) will host an investor webcast on July 29, 2024, to discuss results from the Phase 2 SHINE study of CT1812 in mild-to-moderate Alzheimer's disease. The webcast will cover clinical efficacy, safety, and biomarker findings. Results will also be presented at the Alzheimer's Association's International Conference.

Portfolio Pulse from Benzinga Newsdesk

July 26, 2024 | 8:13 pm

CMCSA

GOOG

GOOGL

Al Michaels will be featured as an AI-generated version of himself for Comcast's coverage of the 2024 Summer Olympics on Peacock. Google, through its Gemini AI, will partner with Team USA and Comcast to enhance Olympic coverage with advanced search and AI features.

Portfolio Pulse from Chris Katje

July 26, 2024 | 8:08 pm

VTVT

vTv Therapeutics Inc. (NASDAQ:VTVT) announced that the FDA has placed a clinical hold on its cadisegliatin clinical program, including the ongoing CATT1 Phase 3 trial in type 1 diabetes. Cadisegliatin is a glucokinase activator that has been well-tolerated in over 500 subjects.

Portfolio Pulse from Benzinga Newsdesk

July 26, 2024 | 8:06 pm

NAMS

NewAmsterdam Pharma (NASDAQ:NAMS) will report topline data from its Phase 3 BROOKLYN clinical trial evaluating Obicetrapib in patients with heterozygous familial hypercholesterolemia on July 29, 2024.

Portfolio Pulse from Benzinga Newsdesk

July 26, 2024 | 8:02 pm

PBR

Petrobras has made a non-binding offer for a share of Galp's Mopane oil field in Namibia. If successful, Petrobras would become the operator of the Mopane field, which has at least 10 billion barrels of oil equivalent. This move is driven by environmental licensing issues for new areas in Brazil.

Portfolio Pulse from Benzinga Newsdesk

July 26, 2024 | 7:59 pm